Le Lézard13m
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced initial results on the combination of the Allurion Program with low-dose GLP-1 ...
Le Lézard13m
Planet Labs PBC Releases Images From Pelican-2
Planet Labs PBC , a leading provider of daily data and insights about Earth, today released first light images from its Pelican-2 satellite of the Port of Laem Chabang in Eastern Thailand, the primary ...
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweightFaster-than-expected enrollment enables ...
JD Supra49m
Key Takeaways from CPPA’s Recent Settlement with an Automotive Manufacturer for Alleged CCPA Violations
On March 12, 2025, the California Privacy Protection Agency (CPPA) published its decision approving a Stipulated Final Order (Order) against a ...